(July 17, 2018, 2:04 PM EDT) -- SILVER SPRING, Md. — Three generic drug manufacturers have voluntarily recalled the high blood pressure and heart failure drug valsartan after discovering that they contain a N-nitrosodimethylamine (NDMA), which is classified as a probable human carcinogen, the Food and Drug Administration announced July 13 and July 16....